Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 118.
A
Abdel-Gadir, A;
Vorasettakarnkij, Y;
Ngamkasem, H;
Nordin, S;
Ako, EA;
Tumkosit, M;
Sucharitchan, P;
... Moon, JC; + view all
(2016)
Ultrafast Magnetic Resonance Imaging for Iron Quantification in Thalassemia Participants in the Developing World The TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR).
Circulation
, 134
(5)
pp. 432-434.
10.1161/CIRCULATIONAHA.116.022803.
|
 |
|
Ahadome, S;
Abraham, DJ;
Rayapureddi, S;
Saw, VP;
Saban, DR;
Calder, VL;
Norman, JT;
... Dart, JK; + view all
(2016)
Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.
Journal of Clinical Investigation insight
, 1
(12)
, Article e87001. 10.1172/jci.insight.87001.
|
|
|
Al-Shawi, R;
Tennent, GA;
Millar, DJ;
Richard-Londt, A;
Brandner, S;
Werring, DJ;
Simons, JP;
(2016)
Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.
Open Biology
, 6
(2)
, Article 150202. 10.1098/rsob.150202.
|
|
|
Allanore, Y;
Denton, CP;
Krieg, T;
Cornelisse, P;
Rosenberg, D;
Schwierin, B;
Matucci-Cerinic, M;
(2016)
Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort.
Annals of the Rheumatic Diseases
, 75
(9)
pp. 1736-1740.
10.1136/annrheumdis-2016-209481.
|
|
|
Ambrose, N;
Morgan, TA;
Galloway, J;
Ionnoau, Y;
Beresford, MW;
Isenberg, DA;
(2016)
Differences in disease phenotype and severity in SLE across age groups.
Lupus
, 25
(14)
pp. 1542-1550.
10.1177/0961203316644333.
|
|
|
Antoniou, KM;
Margaritopoulos, GA;
Goh, NS;
Karagiannis, K;
Desai, SR;
Nicholson, AG;
Siafakas, NM;
... Wells, AU; + view all
(2016)
Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
Arthritis & Rheumatology
, 68
(4)
pp. 1004-1012.
10.1002/art.39528.
|
|
Arachchillage, DRJ;
Mackie, IJ;
Efthymiou, M;
Chitolie, A;
Hunt, BJ;
Isenberg, DA;
Khamashta, M;
... Cohen, H; + view all
(2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Journal of Thrombosis and Haemostasis
, 14
(11)
pp. 2177-2186.
10.1111/jth.13475.
|
|
|
Arbore, G;
West, EE;
Spolski, R;
Robertson, AA;
Klos, A;
Rheinheimer, C;
Dutow, P;
... Kemper, C; + view all
(2016)
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells.
Science
, 352
(6292)
, Article aad1210. 10.1126/science.aad1210.
|
|
|
Attipoe, L;
Bechman, K;
Ciurtin, C;
(2016)
Biologic treatments (other than anti-TNF therapy) licensed for use in rheumatoid arthritis.
In:
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implication.
(pp. 229-258).
Nova Science Publishers: New York, NY, USA.
|
|
|
Attipoe, L;
Bechman, K;
Ciurtin, C;
(2016)
New biologic agents and biosimilars developed for rheumatoid arthritis.
In:
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implication.
(pp. 259-282).
Nova Science Publishers: New York, NY, USA.
|
|
Attipoe, L;
Ciurtin, C;
(2016)
Patient perception of treatment efficacy, disability and health satisfaction.
Presented at: British Society of Rheumatology Annual Conference, Glasgow, UK.
|
B
|
Bechman, K;
Attipoe, L;
Ciurtin, C;
(2016)
Tumour necrosis factor inhibitors used in the treatment of rheumatoid arthritis: Evidence of safety, efficacy and health implication.
In:
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implication.
(pp. 199-228).
Nova Science Publishers: New York, NY, USA.
|
|
|
Bernatsky, S;
Ramsey-Goldman, R;
Petri, M;
Urowitz, MB;
Gladman, DD;
Fortin, PF;
Ginzler, E;
... Clarke, AE; + view all
(2016)
Breast cancer in systemic lupus.
Lupus
, 26
(3)
pp. 311-315.
10.1177/0961203316664595.
|
|
Betteridge, ZE;
Woodhead, F;
Lu, H;
Shaddick, G;
Bunn, CC;
Denton, CP;
Abraham, DJ;
... McHugh, NJ; + view all
(2016)
Anti-Eukaryotic Initiation Factor 2B Autoantibodies are Associated with Interstitial Lung Disease in Patients with Systemic Sclerosis.
Arthritis & Rheumatology
, 68
(11)
pp. 2778-2783.
10.1002/art.39755.
|
|
Brown, J;
Clark, K;
Smith, C;
Hopwood, J;
Lynard, O;
Toolan, M;
Creer, D;
... Lipman, M; + view all
(2016)
Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis.
BMC Infectious Diseases
, 16
(265)
10.1186/s12879-016-1612-1.
|
|
|
Bulluck, H;
Rosmini, S;
Abdel-Gadir, A;
Bhuva, AN;
Treibel, TA;
Fontana, M;
Weinmann, S;
... Hausenloy, DJ; + view all
(2016)
Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance.
Open Heart
, 3
(2)
, Article e000535. 10.1136/openhrt-2016-000535.
|
|
Bulluck, H;
Rosmini, S;
Abdel-Gadir, A;
White, SK;
Bhuva, AN;
Treibel, TA;
Fontana, M;
... Hausenloy, DJ; + view all
(2016)
Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction.
Journal of the American Heart Association
, 5
(7)
, Article e003555. 10.1161/JAHA.116.003555.
|
|
Bulluck, H;
Rosmini, S;
Abdel-Gadir, A;
White, SK;
Bhuva, AN;
Treibel, TA;
Fontana, M;
... Hausenloy, DJ; + view all
(2016)
Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.
CIRCULATION-CARDIOVASCULAR IMAGING
, 9
(10)
, Article e004940. 10.1161/CIRCIMAGING.116.004940.
|
|
Butturini, E;
Gotte, G;
Dell'Orco, D;
Chiavegato, G;
Marino, V;
Canetti, D;
Cozzolino, F;
... Mariotto, S; + view all
(2016)
Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function.
Biochemical Journal
, 473
pp. 3205-3219.
10.1042/BCJ20160294.
|
|
C
|
Camilloni, C;
Sala, BM;
Sormanni, P;
Porcari, R;
Corazza, A;
De Rosa, M;
Zanini, S;
... Ricagno, S; + view all
(2016)
Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability.
Scientific Reports
, 6
, Article 25559. 10.1038/srep25559.
|
|
|
Chesi, G;
Hegde, RN;
Iacobacci, S;
Concilli, M;
Parashuraman, S;
Festa, BP;
Polishchuk, EV;
... Polishchuk, RS; + view all
(2016)
Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
Hepatology
, 63
(6)
pp. 1842-1859.
10.1002/hep.28398.
|
|
|
Chighizola, CB;
Pregnolato, F;
Meroni, PL;
Denton, CP;
Ong, VH;
(2016)
N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis.
Clinical and Experimental Rheumatology
, 34
(5)
S122-S128.
|
|
Ciurtin, C;
Wyszynski, K;
Clarke, R;
Mouyis, M;
Manson, J;
Marra, G;
(2016)
Ultrasound-detected subclinical inflammation was better reflected by the disease activity score (DAS-28) in patients with suspicion of inflammatory arthritis compared to established rheumatoid arthritis.
Clinical Rheumatology
, 35
(10)
pp. 2411-2419.
10.1007/s10067-016-3326-6.
|
|
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
|
|
Custódio Alves, S;
Fasano, S;
Isenberg, DA;
(2016)
Autoimmune gastrointestinal complications in patients with Systemic Lupus Erythematosus: case series and literature review.
Lupus
, 25
(14)
pp. 1509-1519.
10.1177/0961203316655210.
|
|
|
Cutolo, M;
Herrick, AL;
Distler, O;
Becker, MO;
Beltran, E;
Carpentier, P;
Ferri, C;
... CAP Study Investigators; + view all
(2016)
Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.
Arthritis and Rheumatology
, 68
(10)
pp. 2527-2539.
10.1002/art.39718.
|
|
D
|
Denton, CP;
(2016)
Advances in pathogenesis and treatment of systemic sclerosis.
Clinical Medicine
, 16
(1)
pp. 55-60.
10.7861/clinmedicine.16-1-55.
|
|
Denton, CP;
(2016)
Scleroderma Lung Study II—clarity or obfuscation?
Lancet Respiratory Medicine
, 4
(9)
pp. 678-679.
10.1016/S2213-2600(16)30191-6.
|
|
Denton, CP;
Hughes, M;
Gak, N;
Vila, J;
Buch, MH;
Chakravarty, K;
Fligelstone, K;
... Ong, VH; + view all
(2016)
BSR and BHPR guideline for the treatment of systemic sclerosis.
Rheumatology
, 55
(10)
pp. 1906-1910.
10.1093/rheumatology/kew224.
|
|
Domsic, RT;
Nihtyanova, SI;
Wisniewski, SR;
Fine, MJ;
Lucas, M;
Kwoh, CK;
Denton, CP;
(2016)
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis.
Arthritis & Rheumatology
, 68
(4)
pp. 993-1003.
10.1002/art.39490.
|
|
Dungu, JN;
Papadopoulou, SA;
Wykes, K;
Mahmood, I;
Marshall, J;
Valencia, O;
Fontana, M;
... Anderson, LJ; + view all
(2016)
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
Circulation: Heart Failure
, 9
(9)
, Article e003352. 10.1161/CIRCHEARTFAILURE.116.003352.
|
E
|
Ehrenstein, MR;
Wing, C;
(2016)
The BAFFling effects of rituximab in lupus: danger ahead?
Nature Reviews Rheumatology
, 12
(6)
pp. 367-372.
10.1038/nrrheum.2016.18.
|
|
Elyoussfi, S;
Thomas, BJ;
Ciurtin, C;
(2016)
Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
Rheumatology International
, 36
(5)
pp. 603-612.
10.1007/s00296-016-3436-0.
|
|
|
Evans, IC;
Barnes, JL;
Garner, IM;
Pearce, DR;
Maher, TM;
Shi-Wen, X;
Renzoni, EA;
... McAnulty, RJ; + view all
(2016)
Epigenetic Regulation of Cyclooxygenase-2 by methylation of c8orf4 in Pulmonary Fibrosis.
Clinical Science
, 130
(8)
pp. 575-586.
10.1042/CS20150697.
|
|
Evans, RD;
Laing, CM;
Ciurtin, C;
Walsh, SB;
(2016)
Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment.
BMC Musculoskeletal Disorders
, 17
(1)
p. 2.
10.1186/s12891-015-0858-x.
|
|
F
|
Farinha, F;
Abrol, E;
Isenberg, DA;
(2016)
Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus.
[Letter].
Lupus
, 25
(11)
pp. 1278-1279.
10.1177/0961203316631636.
|
|
|
Fasano, S;
Alves, SC;
Isenberg, DA;
(2016)
Current pharmacological treatment of idiopathic inflammatory myopathies.
Expert Review of Clinical Pharmacology
, 9
(4)
pp. 547-558.
10.1586/17512433.2016.1136561.
|
|
Filippidou, N;
Krashias, G;
Pericleous, C;
Rahman, A;
Ioannou, Y;
Giles, I;
Demetriou, C;
... Lambrianides, A; + view all
(2016)
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
Molecular Immunology
, 75
pp. 161-167.
10.1016/j.molimm.2016.05.022.
|
|
Fischer, A;
Denton, CP;
Matucci-Cerinic, M;
Gillies, H;
Blair, C;
Tislow, J;
Nathan, SD;
(2016)
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.
Respir Med
, 117
pp. 254-263.
10.1016/j.rmed.2016.06.018.
|
|
Fontana, M;
(2016)
Prognosis in Cardiac Amyloidosis by LGE.
JACC: Cardiovascular Imaging
, 9
(6)
pp. 687-689.
10.1016/j.jcmg.2015.11.028.
|
|
|
Fontana, M;
(2016)
Systemic amyloidosis by Cardiovascular Magnetic Resonance.
Doctoral thesis , UCL (University College London).
|
|
|
Fontana, M;
Martinez-Naharro, A;
Hawkins, PN;
(2016)
Staging Cardiac Amyloidosis With CMR Understanding the Different Phenotypes.
JACC: Cardiovascular Imaging
, 9
(11)
pp. 1278-1279.
10.1016/j.jcmg.2016.02.035.
|
G
|
Garthwaite, HS;
Porter, JC;
(2016)
Biologic treatments for pulmonary involvment in rheumatic disease.
In: Isenberg, DA and Ciurtin, C, (eds.)
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implications.
(pp. 171-182).
Nova Science Publishers: New York, NY, USA.
|
|
Gattorno, M;
Obici, L;
Cattalini, M;
Tormey, V;
Abrams, K;
Davis, N;
Speziale, A;
... Lachmann, HJ; + view all
(2016)
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
Annals of the Rheumatic Diseases
, 76
(1)
pp. 173-178.
10.1136/annrheumdis-2015-209031.
|
|
Gillmore, JD;
Maurer, MS;
Falk, RH;
Merlini, G;
Damy, T;
Dispenzieri, A;
Wechalekar, AD;
... Hawkins, PN; + view all
(2016)
Non-Biopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Circulation
, 133
(24)
pp. 2404-2412.
10.1161/CIRCULATIONAHA.116.021612.
|
|
Guha, I;
Slamova, I;
Chun, S;
Clegg, A;
Golos, M;
Thrasivoulou, C;
Simons, JP;
(2016)
The effects of short-term JNK inhibition on the survival and growth of aged sympathetic neurons.
Neurobiology of Aging
, 46
pp. 138-148.
10.1016/j.neurobiolaging.2016.06.016.
|
H
|
Heindryckx, F;
Binet, F;
Ponticos, M;
Rombouts, K;
Lau, J;
Kreuger, J;
Gerwins, P;
(2016)
Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.
EMBO Molecular Medicine
, 8
(7)
pp. 729-744.
10.15252/emmm.201505925.
|
|
Howard Tripp, N;
Tarn, J;
Natasari, A;
Gillespie, C;
Mitchell, S;
Hackett, KL;
Bowman, SJ;
... Ng, WF; + view all
(2016)
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines.
RMD Open
, 2
(2)
, Article e000282. 10.1136/rmdopen-2016-000282.
|
I
|
Ikeda, T;
Fragiadaki, M;
Shi-Wen, X;
Ponticos, M;
Khan, K;
Denton, C;
Garcia, P;
... Abraham, D; + view all
(2016)
Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections.
Data in Brief
, 8
pp. 1377-1380.
10.1016/j.dib.2016.08.014.
|
|
Ikeda, T;
Fragiadaki, M;
Shi-wen, X;
Ponticos, M;
Khan, K;
Denton, C;
Garcia, P;
... Abraham, D; + view all
(2016)
Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts.
Biochemistry and Biophysics Reports
, 7
pp. 246-252.
10.1016/j.bbrep.2016.06.022.
|
|
|
Isenberg, DA;
(2016)
Review by Hui-Yuen etal. Targeted B-cell therapies in the treatment of adult and paediatric systemic lupus erythematosus.
Lupus
, 26
(8)
p. 900.
10.1177/0961203316680894.
|
|
J
|
Jaeger, VK;
Wirz, EG;
Allanore, Y;
Rossbach, P;
Riemekasten, G;
Hachulla, E;
Distler, O;
... EUSTAR co-authors, ECA; + view all
(2016)
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
PLoS One
, 11
(10)
, Article e0163894. 10.1371/journal.pone.0163894.
|
|
|
Jewett, LR;
Kwakkenbos, L;
Carrier, M-E;
Malcarne, VL;
Bartlett, SJ;
Furst, DE;
Gottesman, K;
... Thombs, BD; + view all
(2016)
Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.
Clinical and Experimental Rheumatology
, 34
(5)
PI 0092-PF 0099.
|
|
Jones, A;
Giles, IP;
(2016)
Fertility and pregnancy in systemic lupus erythematosus.
Indian Journal of Rheumatology
, 11
(6)
pp. 128-134.
10.4103/0973-3698.194546.
|
|
K
|
Keegan, R;
Waterman, DG;
Hopper, DJ;
Coates, L;
Taylor, G;
Guo, J;
Coker, AR;
... Cooper, JB; + view all
(2016)
The 1.1 angstrom resolution structure of a periplasmic phosphate-binding protein from Stenotrophomonas maltophilia: a crystallization contaminant identified by molecular replacement using the entire Protein Data Bank.
Acta Crystallographica Section D: Structural Biology
, D72
(8)
pp. 933-943.
10.1107/S2059798316010433.
|
|
|
Kellman, P;
Xue, H;
Olivieri, LJ;
Cross, RR;
Grant, EK;
Fontana, M;
Ugander, M;
... Hansen, MS; + view all
(2016)
Dark blood late enhancement imaging.
Journal of Cardiovascular Magnetic Resonance
, 18
, Article 77. 10.1186/s12968-016-0297-3.
|
|
|
Khanna, D;
Berrocal, VJ;
Giannini, EH;
Seibold, JR;
Merkel, PA;
Mayes, MD;
Baron, M;
... Furst, DE; + view all
(2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.
Arthritis Care & Research
, 68
(2)
pp. 167-178.
10.1002/acr.22804.
|
|
Khanna, D;
Berrocal, VJ;
Giannini, EH;
Seibold, JR;
Merkel, PA;
Mayes, MD;
Baron, M;
... Furst, DE; + view all
(2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.
Arthritis & Rheumatology
, 68
(2)
pp. 299-311.
10.1002/art.39501.
|
|
Khanna, D;
Denton, CP;
Jahreis, A;
van Laar, JM;
Frech, TM;
Anderson, ME;
Baron, M;
... Furst, DE; + view all
(2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Lancet
, 387
(10038)
pp. 2630-2640.
10.1016/S0140-6736(16)00232-4.
|
|
Khanna, D;
Denton, CP;
Merkel, PA;
Krieg, T;
Le Brun, F-O;
Marr, A;
Papadakis, K;
... Furst, DE; + view all
(2016)
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis DUAL-1 and DUAL-2 Randomized Clinical Trials.
JAMA: Journal Of The American Medical Association
, 315
(18)
pp. 1975-1988.
10.1001/jama.2016.5258.
|
|
Kirresh, A;
Everitt, A;
Kon, OM;
DasGupta, R;
Pickering, MC;
Lachmann, HJ;
(2016)
Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
Practical Neurology
, 16
(4)
pp. 304-307.
10.1136/practneurol-2015-001342.
|
|
|
Kisilevsky, R;
Raimondi, S;
Bellotti, V;
(2016)
Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting.
Frontiers in Molecular Biosciences
, 3
, Article 17. 10.3389/fmolb.2016.00017.
|
|
L
|
Lane, T;
(2016)
The impact of cytokine modulation in acquired and inherited inflammatory disease and AA amyloidosis.
Doctoral thesis , UCL (University College London).
|
|
Leblond, V;
Kastritis, E;
Advani, R;
Ansell, SM;
Buske, C;
Castillo, JJ;
Garcia-Sanz, R;
... Dimopoulos, MA; + view all
(2016)
Treatment recommendations from the Eighth International Workshop on Waldenstrom's Macroglobulinemia.
Blood
, 128
(10)
pp. 1321-1328.
10.1182/blood-2016-04-711234.
|
|
Leri, M;
Bemporad, F;
Oropesa-Nunez, R;
Canale, C;
Calamai, M;
Nosi, D;
Ramazzotti, M;
... Bucciantini, M; + view all
(2016)
Molecular insights into cell toxicity of a novel familial amyloidogenic variant of beta 2-microglobulin.
Journal of Cellular and Molecular Medicine
, 20
(8)
pp. 1443-1456.
10.1111/jcmm.12833.
|
|
Lopes da Silva, M;
O'Connor, MN;
Kriston-Vizi, J;
White, IJ;
Al-Shawi, R;
Simons, JP;
Mössinger, J;
... Cutler, DF; + view all
(2016)
Type II PI4-kinases control Weibel-Palade body biogenesis and von Willebrand factor structure in human endothelial cells.
Journal of Cell Science
, 129
(10)
pp. 2096-2105.
10.1242/jcs.187864.
|
|
|
López-Isac, E;
Martín, JE;
Assassi, S;
Simeón, CP;
Carreira, P;
Ortego-Centeno, N;
Freire, M;
... Martín, J; + view all
(2016)
Cross-disease Meta-analysis of Genome-wide Association Studies for Systemic Sclerosis and Rheumatoid Arthritis Reveals IRF4 as a New Common Susceptibility Locus.
Arthritis & Rheumatology
, 68
(9)
pp. 2338-2344.
10.1002/art.39730.
|
|
Lynch, BM;
Stern, EP;
Ong, V;
Harber, M;
Burns, A;
Denton, CP;
(2016)
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.
Clinical and Experimental Rheumatology
, 34
(5)
, Article Sup 100.
|
|
M
|
Maciocia, N;
Wechalekar, A;
Yong, K;
(2016)
Monoclonal gammopathy of undetermined significance and smoldering myeloma (SMM): a practical guide to management.
Hematological Oncology
, 35
(4)
pp. 432-439.
10.1002/hon.2345.
|
|
|
Mahmood, S;
Wassef, NL;
Salter, SJ;
Sachchithanantham, S;
Lane, T;
Foard, D;
Whelan, CJ;
... Wechalekar, AD; + view all
(2016)
Comparison of Free Light Chain Assays Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
American Journal of Clinical Pathology
, 146
(1)
pp. 78-85.
10.1093/ajcp/aqw079.
|
|
|
McDonnell, TCR;
(2016)
Does PEGylated DI have the potential to be an effective therapeutic for Antiphospholipid Syndrome?
Doctoral thesis , UCL (University College London).
|
|
Medina-Quinones, CV;
Ramos-Merino, L;
Ruiz-Sada, P;
Isenberg, D;
(2016)
Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period.
Arthritis Care and Research
, 68
(7)
pp. 981-987.
10.1002/acr.22774.
|
|
Menon, M;
Blair, PA;
Isenberg, DA;
Mauri, C;
(2016)
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus.
Immunity
, 44
(3)
pp. 683-697.
10.1016/j.immuni.2016.02.012.
|
|
|
Merlini, G;
Lousada, I;
Ando, Y;
Dispenzieri, A;
Gertz, MA;
Grogan, M;
Maurer, MS;
... Comenzo, RL; + view all
(2016)
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.
Leukemia
, 30
(10)
pp. 1979-1986.
10.1038/leu.2016.191.
|
|
|
Morais, SA;
du Preez, HE;
Akhtar, MR;
Cross, S;
Isenberg, DA;
(2016)
Musculoskeletal complications of haematological disease.
Rheumatology
, 55
(6)
pp. 968-981.
10.1093/rheumatology/kev360.
|
|
Morais, SA;
Isenberg, DA;
(2016)
A study of the influence of ethnicity on serology and clinical features in lupus.
Lupus
, 26
(1)
pp. 17-26.
10.1177/0961203316645204.
|
|
Mouyis, M;
Ciurtin, C;
Isenberg, D;
(2016)
Biologic therapies for systemic lupus erythematosus: where are we now?
In: Ciurtin, C and Isenberg, D, (eds.)
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implication.
Nova Science Publishers: New York, USA.
|
|
N
|
Nanthapisal, S;
Murphy, C;
Omoyinmi, E;
Hong, Y;
Standing, A;
Gilmour, K;
Berg, S;
... Brogan, P; + view all
(2016)
Deficiency of adenosine deaminase type 2 (DADA2): a description of phenotype and genotype in 15 cases.
Arthritis and Rheumatology
, 68
(9)
pp. 2314-2322.
10.1002/art.39699.
|
|
Natalello, A;
Mangione, PP;
Giorgetti, S;
Porcari, R;
Marchese, L;
Zorzoli, I;
Relini, A;
... Raimondi, S; + view all
(2016)
Co-fibrillogenesis of Wild-type and D76N β₂-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS.
Journal of Biological Chemistry
, 291
(18)
pp. 9678-9689.
10.1074/jbc.M116.720573.
|
|
|
Nguyen, DX;
Ehrenstein, MR;
(2016)
Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis.
Journal of Experimental Medicine
, 213
(7)
pp. 1241-1253.
10.1084/jem.20151255.
|
O
|
Omoyinmi, E;
Hamaoui, R;
Bryant, A;
Jiang, MC;
Athigapanich, T;
Eleftheriou, D;
Hubank, M;
... Woo, P; + view all
(2016)
Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study.
Pediatric Rheumatology
, 14
(1)
p. 7.
10.1186/s12969-016-0067-7.
|
|
|
Ozawa, D;
Nomura, R;
Mangione, PP;
Hasegawa, K;
Okoshi, T;
Porcari, R;
Bellotti, V;
(2016)
Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
Scientific Reports
, 6
, Article 29077. 10.1038/srep29077.
|
|
P
|
Parkes, J;
Rothwell, S;
Day, P;
McHugh, NJ;
Betteridge, Z;
Cooper, R;
Ollier, WE;
... Lamb, J; + view all
(2016)
Systematic Protein-Protein Interaction and Pathway Analyses in the Idiopathic Inflammatory Myopathies.
Arthritis Research & Therapy
, 18
, Article 156. 10.1186/s13075-016-1061-7.
|
|
Pepys, MB;
(2016)
Immunotherapeutic clearance of systemic amyloid deposits by antibodies to serum amyloid P component.
Amyloid
, 24
(Supp 1)
10.1080/13506129.2016.1269735.
|
|
Pericleous, C;
Ferreira, I;
Borghi, O;
Pregnolato, F;
McDonnell, T;
Garza-Garcia, A;
Driscoll, P;
... Rahman, A; + view all
(2016)
Measuring IgA anti-β2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome.
PLoS One
, 11
(6)
, Article e0156407. 10.1371/journal.pone.0156407.
|
|
|
Pourcet, B;
Gage, MC;
León, TE;
Waddington, KE;
Pello, OM;
Steffensen, KR;
Castrillo, A;
... Pineda-Torra, I; + view all
(2016)
The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms.
Scientific Reports
, 6
, Article 25481. 10.1038/srep25481.
|
|
|
Pujades-Rodriguez, M;
Duyx, B;
Thomas, SL;
Stogiannis, D;
Rahman, A;
Smeeth, L;
Hemingway, H;
(2016)
Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England.
PLoS One
, 11
(3)
, Article e0151245. 10.1371/journal.pone.0151245.
|
|
Q
|
Quillinan, NP;
(2016)
Treatment of Diffuse Cutaneous Systemic Sclerosis with Hyperimmune Caprine Serum.
Doctoral thesis , UCL (University College London).
|
|
R
|
Rahman, A;
(2016)
Antiphospholipid syndrome in pregnancy.
[Review].
Indian Journal of Rheumatology
, 11
(6)
S117-S121.
10.4103/0973-3698.194543.
|
|
|
Raja, J;
Denton, CP;
(2016)
Emerging evidence-based therapies for systemic sclerosis.
Indian Journal of Rheumatology
, 11
(3)
pp. 153-163.
10.4103/0973-3698.187423.
|
|
|
Raja, J;
Nihtyanova, SI;
Murray, CD;
Denton, CP;
Ong, VH;
(2016)
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis.
Rheumatology
, 55
(1)
pp. 115-119.
10.1093/rheumatology/kev318.
|
|
|
Reddy, V;
Martinez, L;
Isenberg, DA;
Leandro, MJ;
Cambridge, G;
(2016)
Pragmatic treatment of patients with Systemic Lupus Erythematosus with rituximab: Long-term effects on serum immunoglobulins.
Arthritis Care Res (Hoboken)
, 69
(6)
pp. 857-866.
10.1002/acr.22993.
|
|
Rosmini, S;
Treibel, TA;
Bandula, S;
Stroud, T;
Fontana, M;
Hawkins, PN;
Moon, JC;
(2016)
Cardiac computed tomography for the detection of cardiac amyloidosis.
Journal of Cardiovascular Computed Tomography
, 11
(2)
pp. 155-156.
10.1016/j.jcct.2016.09.001.
|
|
Rosser, EC;
Mauri, C;
(2016)
A clinical update on the significance of the gut microbiota in systemic autoimmunity.
Journal of Autoimmunity
, 74
pp. 85-93.
10.1016/j.jaut.2016.06.009.
|
|
Rowczenio, DM;
Trojer, H;
Omoyinmi, E;
Arostegui, JI;
Arakelov, G;
Mensa-Vilaro, A;
Baginska, A;
... Lachmann, HJ; + view all
(2016)
Brief Report: Association of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion.
Arthritis & Rheumatology
, 68
(8)
pp. 2044-2049.
10.1002/art.39683.
|
|
|
Ruberg, FL;
Fontana, M;
Gillmore, JD;
(2016)
Should Histologic Determination of Amyloid Load Determine Management Decisions in Light-Chain Amyloidosis?
J Am Coll Cardiol
, 68
(22)
pp. 2493-2494.
10.1016/j.jacc.2016.07.786.
|
|
Rydén-Aulin, M;
Boumpas, D;
Bultink, I;
Callejas Rubio, JL;
Caminal-Montero, L;
Castro, A;
Colodro Ruiz, A;
... van Vollenhoven, R; + view all
(2016)
Off-label use of rituximab for systemic lupus erythematosus in Europe.
LUPUS Science & Medicine
, 3
(1)
, Article e000163. 10.1136/lupus-2016-000163.
|
|
S
|
Sachchithanantham, S;
Roussel, M;
Palladini, G;
Klersy, C;
Mahmood, S;
Venner, CP;
Gibbs, S;
... Wechalekar, AD; + view all
(2016)
European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis.
Journal of Clinical Oncology
, 34
(17)
pp. 2037-2045.
10.1200/JCO.2015.63.3123.
|
|
Sartiani, L;
Bucciantini, M;
Spinelli, V;
Leri, M;
Natalello, A;
Nosi, D;
Maria Doglia, S;
... Stefani, M; + view all
(2016)
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.
Biophys J
, 111
(9)
pp. 2024-2038.
10.1016/j.bpj.2016.09.010.
|
|
Silva, MA;
Cogollo, E;
Isenberg, DA;
(2016)
Why do patients with myositis die? A retrospective analysis of a single-centre cohort.
Clinical and Experimental Rheumatology
, 34
(5)
pp. 820-826.
1593-098X.
|
|
Sivakumaran, P;
Hussain, S;
Gill, A;
Dhas, D;
Manson, J;
Ciurtin, C;
(2016)
KEY DIFFERENCES BETWEEN OSTEOARTHRITIS AND SEROPOSITIVE RHEUMATOID ARTHRITIS ON HAND ULTRASOUND.
Presented at: Annual Meeting of the British-Society-for-Rheumatology, British-Health-Professionals-in-Rheumatology and the British-Society-for-Paediatric-and-Adolescent-Rheumatology (Rheumatology), Glasgow, Scotland.
|
 |
|
Slamova, I;
(2016)
Modelling Amyloidosis in Mice.
Doctoral thesis , UCL (University College London).
|
|
|
Smith, E;
Croca, S;
Waddington, K;
Sofat, R;
Griffin, M;
Nicolaides, A;
Isenberg, D;
... Jury, EC; + view all
(2016)
Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque.
Science Immunology
, 1
(6)
, Article eaah4081. 10.1126/sciimmunol.aah4081.
|
|
Smith, EC;
(2016)
The role of invariant Natural Killer T cells in SLE patients with atherosclerosis.
Doctoral thesis , UCL (University College London).
|
|
Sobanski, V;
Giovannelli, J;
Lynch, BM;
Schreiber, BE;
Nihtyanova, SI;
Harvey, J;
Handler, CE;
... Coghlan, JG; + view all
(2016)
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Arthritis & Rheumatology
, 68
(2)
pp. 484-493.
10.1002/art.39432.
|
|
T
|
Taylor, SJC;
Carnes, D;
Homer, K;
Kahan, BC;
Hounsome, N;
Eldridge, S;
Spencer, A;
... Underwood, M; + view all
(2016)
Novel Three-Day, Community-Based, Nonpharmacological Group Intervention for Chronic Musculoskeletal Pain (COPERS): A Randomised Clinical Trial.
PLoS Medicine
, 13
(6)
, Article e1002040. 10.1371/journal.pmed.1002040.
|
|
Ter Haar, NM;
Annink, KV;
Al-Mayouf, SM;
Amaryan, G;
Anton, J;
Barron, KS;
Benseler, SM;
... Frenkel, J; + view all
(2016)
Development of the autoinflammatory disease damage index (ADDI).
Annals of the Rheumatic Diseases
, 76
pp. 821-830.
10.1136/annrheumdis-2016-210092.
|
|
Ter Haar, NM;
Jeyaratnam, J;
Lachmann, HJ;
Simon, A;
Brogan, PA;
Doglio, M;
Cattalini, M;
... Eurofever Project, .; + view all
(2016)
The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever Registry.
Arthritis & Rheumatology
, 68
(11)
pp. 2795-2805.
10.1002/art.39763.
|
|
Thomas, BJ;
Elyoussfi, S;
Ciurtin, C;
(2016)
Established and new biologic therapies for psoriatic arthritis and psoriasis.
In:
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implication.
(pp. 307-345).
Nova Science Publishers: New York, NY, USA.
|
|
Thompson, N;
Isenberg, DA;
Jury, EC;
Ciurtin, C;
(2016)
Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjogren's syndrome.
Rheumatology
, 55
(9)
pp. 1548-1555.
10.1093/rheumatology/kev420.
|
|
|
Thompson, NL;
Isenberg, DA;
Jury, E;
Ciurtin, C;
(2016)
Differential peripheral B cell phenotype in patients with primary Sjögren’s syndrome (pSS) compared to secondary Sjögren’s syndrome associated with systemic lupus erythematosus (SS/SLE).
Presented at: BSI NVVI 2016 Congress, Liverpool, United Kingdom.
|
|
Tougaard, BG;
Pedersen, KV;
Krag, SR;
Gilbertson, JA;
Rowczenio, D;
Gillmore, JD;
Birn, H;
(2016)
A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype.
European Journal of Medical Genetics
, 59
(9)
pp. 474-477.
10.1016/j.ejmg.2016.05.015.
|
|
Treibel, TA;
Fontana, M;
Gilbertson, JA;
Castelletti, S;
White, SK;
Scully, PR;
Roberts, N;
... Moon, JC; + view all
(2016)
Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis. Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
Circulation: Cardiovascular Imaging
, 9
(8)
, Article e005066. 10.1161/CIRCIMAGING.116.005066.
|
|
V
|
Valleix, S;
Verona, G;
Jourde-Chiche, N;
Nédelec, B;
Mangione, PP;
Bridoux, F;
Mangé, A;
... Bellotti, V; + view all
(2016)
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.
Nature Communications
, 7
, Article 10353. 10.1038/ncomms10353.
|
|
|
van Vollenhoven, R;
Voskuyl, A;
Bertsias, G;
Aranow, C;
Aringer, M;
Arnaud, L;
Askanase, A;
... Ward, M; + view all
(2016)
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).
Annals of the Rheumatic Diseases
10.1136/annrheumdis-2016-209519.
|
|
|
Velo-García, A;
Castro, SG;
Isenberg, DA;
(2016)
The diagnosis and management of the haematologic manifestations of lupus.
Journal of Autoimmunity
, 74
pp. 139-160.
10.1016/j.jaut.2016.07.001.
|
|
Velo-García, A;
Ntatsaki, E;
Isenberg, D;
(2016)
The safety of pharmacological treatment options for lupus nephritis.
Expert Opinion on Drug Safety
, 15
(8)
pp. 1041-1054.
10.1080/14740338.2016.1182496.
|
W
|
Walker, UA;
Hoffman, HM;
Williams, R;
Kuemmerle-Deschner, J;
Hawkins, PN;
(2016)
Severe Inflammation Following Vaccination Against Streptococcus pneumoniae in Patients With Cryopyrin-Associated Periodic Syndromes.
Arthritis & Rheumatology
, 68
(2)
pp. 516-520.
10.1002/art.39482.
|
|
